Related Experiment Video

Updated: Aug 25, 2025

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.0K

Improving outcomes in malignant pleural mesothelioma in an integrated health care system

Stephanie Ossowski1, Yun-Yi Hung2, Kian Banks3

  • 1Department of Hematology/Oncology, Kaiser San Francisco Medical Center, San Francisco, CA, USA.

Journal of Thoracic Disease
|October 17, 2022
PubMed
Abstract

Insights

Specialized surgical teams and multidisciplinary reviews improve malignant pleural mesothelioma (MPM) treatment. Patients receiving comprehensive therapy, including surgery, experienced a 12-month increase in overall survival (OS).

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Cancer Research

Background:

  • Malignant pleural mesothelioma (MPM) is a rare, aggressive thoracic cancer.
  • Effective management requires experienced surgical and multidisciplinary teams.
  • The impact of surgical specialization and case review on MPM outcomes is under investigation.

Purpose of the Study:

  • To evaluate the effect of proficient surgeons and MPM bi-disciplinary review on patient outcomes.
  • To compare treatment patterns and survival rates before and after regionalizing MPM surgeries to specialized centers.

Main Methods:

  • A cohort study reviewed 368 adult MPM patient records (2009-2020).
  • Survival rates were compared using Kaplan-Meier and log-rank tests.
  • Cox proportional hazards regression analyzed overall survival (OS) with adjustments for clinical factors.

Main Results:

  • More patients received MPM-directed treatment from 2015-2020 compared to 2009-2014.
  • An increase in pleurectomy/decortication (PD) was observed in the later period.
  • Multimodality therapy improved OS by 12 months compared to no treatment in similar patients.

Conclusions:

  • Centralizing mesothelioma surgery to specialized teams enhances surgical treatment incorporation.
  • Regular bi-disciplinary review aids in determining optimal multimodality therapy for MPM.
  • This approach improves management and outcomes for malignant pleural mesothelioma patients.
Keywords:
Malignant pleural mesothelioma (MPM)multimodality therapyoverall survival (OS)pleurectomy/decortication (PD)regionalization

More Related Videos

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.3K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.9K

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
280
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
250
Integrated Healthcare System01:20

Integrated Healthcare System

An integrated healthcare system (IHS) is a set of organizations that provides for or arranges to provide coordinated and continuous service to a defined population. The IHS takes responsibility for that particular population's health status and outcome, both clinically and fiscally. An integrated healthcare system is a well-organized, well-coordinated, and collaborative network. The integrated delivery system is a network that connects different healthcare providers to deliver organized,...
1.8K
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
226
Pleura of the Lungs01:13

Pleura of the Lungs

The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
2.8K
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.6K